A.V. Wallace

1.2k total citations
20 papers, 706 citations indexed

About

A.V. Wallace is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, A.V. Wallace has authored 20 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Physiology and 4 papers in Organic Chemistry. Recurrent topics in A.V. Wallace's work include Nitric Oxide and Endothelin Effects (8 papers), Metal-Catalyzed Oxygenation Mechanisms (4 papers) and Adenosine and Purinergic Signaling (4 papers). A.V. Wallace is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Metal-Catalyzed Oxygenation Mechanisms (4 papers) and Adenosine and Purinergic Signaling (4 papers). A.V. Wallace collaborates with scholars based in United Kingdom, United States and Sweden. A.V. Wallace's co-authors include Miles D. Houslay, Alan C. Tinker, C M Heyworth, Peter Hamley, Haydn G. Beaton, David Nicholls, Sally Wilson, John Unitt, N. K. Boughton-Smith and R.J. Rosenfeld and has published in prestigious journals such as Biochemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

A.V. Wallace

20 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.V. Wallace United Kingdom 15 326 198 165 85 77 20 706
Giuseppina Morini Italy 17 257 0.8× 181 0.9× 184 1.1× 65 0.8× 99 1.3× 74 799
Jill M. McFadden United States 13 790 2.4× 213 1.1× 206 1.2× 76 0.9× 222 2.9× 17 1.3k
R. Keith Webber United States 8 205 0.6× 524 2.6× 156 0.9× 200 2.4× 39 0.5× 9 878
Nanaya TAMAKI Japan 20 589 1.8× 315 1.6× 127 0.8× 135 1.6× 53 0.7× 63 1.1k
Elwood Largis United States 16 422 1.3× 308 1.6× 169 1.0× 93 1.1× 238 3.1× 30 977
O. Morand France 13 622 1.9× 304 1.5× 108 0.7× 160 1.9× 113 1.5× 17 975
Bernard P. Kok United States 15 681 2.1× 186 0.9× 103 0.6× 157 1.8× 76 1.0× 23 1.1k
J. G. T. Sneyd New Zealand 10 576 1.8× 251 1.3× 54 0.3× 99 1.2× 183 2.4× 17 914
Yoshiaki Yamashita Japan 13 157 0.5× 248 1.3× 71 0.4× 142 1.7× 52 0.7× 41 679
Hélène Perrier Canada 13 531 1.6× 185 0.9× 217 1.3× 92 1.1× 39 0.5× 19 944

Countries citing papers authored by A.V. Wallace

Since Specialization
Citations

This map shows the geographic impact of A.V. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.V. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.V. Wallace more than expected).

Fields of papers citing papers by A.V. Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.V. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.V. Wallace. The network helps show where A.V. Wallace may publish in the future.

Co-authorship network of co-authors of A.V. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of A.V. Wallace. A scholar is included among the top collaborators of A.V. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.V. Wallace. A.V. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dao, Vu Thao-Vi, Mahmoud H. Elbatreek, Thomas Fuchß, et al.. (2020). Nitric Oxide Synthase Inhibitors into the Clinic at Last. Handbook of experimental pharmacology. 264. 169–204. 17 indexed citations
2.
Mallinder, Philip R., A.V. Wallace, & Gary Allenby. (2009). Identification of iNOS Inhibitors Using InteraX™. SLAS DISCOVERY. 14(3). 263–272. 3 indexed citations
3.
Tinker, Alan C. & A.V. Wallace. (2006). Selective Inhibitors of Inducible Nitric Oxide Synthase: Potential Agents for the Treatment of Inflammatory Diseases?. Current Topics in Medicinal Chemistry. 6(2). 77–92. 92 indexed citations
4.
Baxter, Andrew, et al.. (2005). Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(4). 960–963. 44 indexed citations
5.
Connolly, Stephen, Anders Åberg, A.S. Arvai, et al.. (2004). 2-Aminopyridines as Highly Selective Inducible Nitric Oxide Synthase Inhibitors. Differential Binding Modes Dependent on Nitrogen Substitution. Journal of Medicinal Chemistry. 47(12). 3320–3323. 37 indexed citations
6.
Tinker, Alan C., Haydn G. Beaton, N. K. Boughton-Smith, et al.. (2003). 1,2-Dihydro-4-quinazolinamines:  Potent, Highly Selective Inhibitors of Inducible Nitric Oxide Synthase Which Show Antiinflammatory Activity in Vivo. Journal of Medicinal Chemistry. 46(6). 913–916. 87 indexed citations
7.
Rosenfeld, R.J., Elsa D. Garcin, Koustubh Panda, et al.. (2002). Conformational Changes in Nitric Oxide Synthases Induced by Chlorzoxazone and Nitroindazoles:  Crystallographic and Computational Analyses of Inhibitor Potency. Biochemistry. 41(47). 13915–13925. 57 indexed citations
8.
Beaton, Haydn G., Peter Hamley, David Nicholls, Alan C. Tinker, & A.V. Wallace. (2001). 3,4-Dihydro-1-isoquinolinamines: A novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency. Bioorganic & Medicinal Chemistry Letters. 11(8). 1023–1026. 32 indexed citations
9.
Beaton, Haydn G., N. K. Boughton-Smith, Peter Hamley, et al.. (2001). Thienopyridines: nitric oxide synthase inhibitors with potent In vivo activity. Bioorganic & Medicinal Chemistry Letters. 11(8). 1027–1030. 20 indexed citations
10.
Unitt, John, et al.. (1999). Novel Cobalt Complex Inhibitors of Mitochondrial Calcium Uptake. Bioorganic & Medicinal Chemistry. 7(9). 1891–1896. 21 indexed citations
11.
Wallace, A.V., et al.. (1993). Extracellular calcium modulates insulin's action on enzymes controlling cyclic AMP metabolism in intact hepatocytes. Biochemical Journal. 293(1). 249–253. 12 indexed citations
12.
Palmer, Gene C., et al.. (1992). Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze. Neuroreport. 3(10). 922–924. 42 indexed citations
13.
Navaratnam, Naveenan, et al.. (1990). Subcellular compartmentation in the synthesis of the milk sugars lactose and ?-2,3-sialyllactose. PROTOPLASMA. 159(2-3). 144–156. 13 indexed citations
14.
Wallace, A.V. & Nicholas J. Kuhn. (1986). Incorporation into phospholipid vesicles of pore-like properties from Golgi membranes of lactating-rat mammary gland. Biochemical Journal. 236(1). 91–96. 4 indexed citations
15.
16.
Heyworth, C M, A.V. Wallace, Sally Wilson, & Miles D. Houslay. (1984). An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations. Biochemical Journal. 222(1). 183–187. 32 indexed citations
17.
Houslay, Miles D., et al.. (1984). Does insulin exert certain of its actions through a distinct species of guanine nucleotide regulatory protein?. Biochemical Society Transactions. 12(5). 766–768. 9 indexed citations
18.
Wilson, Sally, A.V. Wallace, & Miles D. Houslay. (1983). Insulin activates the plasma-membrane and dense-vesicle cyclic AMP phosphodiesterase in hepatocytes by distinct routes. Biochemical Journal. 216(1). 245–248. 15 indexed citations
19.
Heyworth, C M, A.V. Wallace, & Miles D. Houslay. (1983). Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. Biochemical Journal. 214(1). 99–110. 135 indexed citations
20.
Whetton, Anthony D., Axel Johannsson, Sally Wilson, A.V. Wallace, & Miles D. Houslay. (1982). The thermodependence of the activity of integral enzymes in liver plasma membranes. FEBS Letters. 143(1). 147–152. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppina Morini Breakdown of academic impact, for papers by Jill M. McFadden Breakdown of academic impact, for papers by R. Keith Webber Breakdown of academic impact, for papers by Nanaya TAMAKI Breakdown of academic impact, for papers by Elwood Largis Breakdown of academic impact, for papers by O. Morand Breakdown of academic impact, for papers by Bernard P. Kok Breakdown of academic impact, for papers by J. G. T. Sneyd Breakdown of academic impact, for papers by Yoshiaki Yamashita Breakdown of academic impact, for papers by Hélène Perrier
Rankless by CCL
2026